Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

A

Ali Mohamed AbdEl-Halim Ali Mehanna

Status

Unknown

Conditions

Echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT03638245
USCU 230

Details and patient eligibility

About

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Full description

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester. Study Hypothesis: In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately. Study Question: In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately? Study Objectives: This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.

Enrollment

148 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

1. Women between 30-40 weeks gestational age. 2. Women pregnant in singleton fetus.

Exclusion criteria

1. Multiple pregnancies. 2. Fetal congenital malformation.

Trial design

148 participants in 2 patient groups

Abnormal CTG
Description:
This group includes pregnancies that showed abnormalities in CTG.
Normal CTG
Description:
This group includes pregnancies that showed no abnormalities in CTG.

Trial contacts and locations

0

Loading...

Central trial contact

Ali MA Mehanna, MSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems